Drug intelligence / Profile preview

portulaca oleracea extract

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Portulaca oleracea extract is derived from the plant Portulaca oleracea, commonly known as purslane. It is a medicinal and edible plant widely used in traditional medicine for its anti-inflammatory, antioxidant, wound healing, hepatoprotective, antidiabetic, anticancer/antitumor, neuroprotective, and gastroprotective properties. The extract contains bioactive compounds such as omega-3 fatty acids (notably α-linolenic acid), polyphenols, flavonoids, polysaccharides, vitamins (including β-carotene), minerals, phenolic acids and coumarins. Mechanistically, it exhibits anti-inflammatory effects by inhibiting cyclooxygenase enzymes COX1 and COX2 and modulating cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukins IL-1beta and IL-10. It also modulates cholesterol metabolism by promoting cholesterol efflux via ABCA1/ABCG1 transporters while downregulating CD36 receptor expression in macrophages. This contributes to lipid-lowering effects relevant to atherosclerosis treatment distinct from statins. Traditionally used for inflammatory conditions including skin inflammation and enteritis/dysentery; modern research supports its use in reducing gut microbiota imbalance and colorectal cancer progression through Wnt/β-catenin signaling inhibition. Purslane extracts are found in some topical cosmetic products for soothing irritated skin due to their antioxidant content.

Brand names
Portusana
Other names
purslanehorse's teeth amaranthma chi xianmachixianportulaca neglecta topportulaca oleracea flower/leaf/stem extractportulaca oleracea flowering topportulaca oleracea topportulaca retusa topportulaceae herbapurslane herb
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ABCA1 (ATP-binding cassette transporter A1)ABCG1 (ATP-binding cassette sub-family G member 1)CD36 (CD36 antigen)IL1B (Interleukin-1 beta)IL10 (Interleukin-10)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on portulaca oleracea extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on portulaca oleracea extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call